Simponi aria and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Simponi aria (golimumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Namenda, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Simponi aria. It is created by eHealthMe based on reports of 3,676 people who have side effects when taking Simponi aria from the FDA, and is updated regularly.

What is Simponi aria?

Simponi aria has active ingredients of golimumab. eHealthMe is studying from 3,704 Simponi aria users. Check the latest studies of Simponi aria.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,807 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 13, 2026

3,676 people reported to have side effects when taking Simponi aria.
Among them, 15 people (0.41%) have Chronic obstructive pulmonary disease.

Could Simponi aria cause Chronic obstructive pulmonary disease?

Among these 15 people:

How long have people been on Simponi aria when they have Chronic obstructive pulmonary disease? *

What is the gender of people who have Chronic obstructive pulmonary disease when taking Simponi aria? *

female: 80 %
male: 20 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Simponi aria? *

What are other drugs people take besides Simponi aria? *

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Pneumonia: 10 people, 66.67%
Large Intestinal Ulcer: 3 people, 20.00%
Acute Respiratory Failure: 3 people, 20.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 20.00%
Respiratory Distress (difficulty in breathing): 2 people, 13.33%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 2 people, 13.33%
Abdominal Pain Upper: 2 people, 13.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 1 person, 6.67%
Acute Myocardial Infarction (acute heart attack): 1 person, 6.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 80.00%
Osteoporosis (bones weak and more likely to break): 4 people, 26.67%
Pain: 4 people, 26.67%
Blood Potassium Decreased: 4 people, 26.67%
Constipation: 4 people, 26.67%
Gout (uric acid crystals building up in the body): 4 people, 26.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 26.67%
Insomnia (sleeplessness): 4 people, 26.67%
Irritable Bowel Syndrome: 4 people, 26.67%
Swelling: 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Simponi aria and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simponi aria:

Simponi aria (3,704 reports)

Browse all side effects of Simponi aria:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,807 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

Related publications that referenced our studies

Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on golimumab (the active ingredients of Simponi aria) and Simponi aria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.